CA15-3 ELISA Kit

Name CA15-3 ELISA Kit
Supplier Sigma-Aldrich
Catalog SE120153
Category ELISA Kit
Prices $360.50
Sizes 1 kt
Range 0-240 μg/mL
Precision inter-assay cv: <10 % intra-assay cv: <10 %
Applications ELISA
Species Reactivities Human
Description The CA15-3 ELISA Kit is intended for the quantitative determination of the Cancer Antigen CA15-3 concentration in human serum
Gene MUC1
Supplier Page Shop

Product References

Prediction of relapse and survival in breast cancer patients by pS2 protein - Prediction of relapse and survival in breast cancer patients by pS2 protein

Foekens JA, Rio MC, Seguin P, van Putten WL, Fauque J, Nap M, Klijn JG, Chambon P. Cancer Res. 1990 Jul 1;50(13):3832-7.

Prediction of relapse or survival in patients with node-negative breast cancer by - Prediction of relapse or survival in patients with node-negative breast cancer by

Clark GM, Dressler LG, Owens MA, Pounds G, Oldaker T, McGuire WL. N Engl J Med. 1989 Mar 9;320(10):627-33.

Cathepsin D as a prognostic indicator for node-negative breast cancer patients - Cathepsin D as a prognostic indicator for node-negative breast cancer patients

Kute TE, Shao ZM, Sugg NK, Long RT, Russell GB, Case LD. Cancer Res. 1992 Oct 1;52(19):5198-203.

Quantitation of estrogen and progesterone receptors by immunocytochemical and - Quantitation of estrogen and progesterone receptors by immunocytochemical and

Aziz DC. Am J Clin Pathol. 1992 Jul;98(1):105-11.

Prognostic factors and therapeutic decisions in axillary node-negative breast - Prognostic factors and therapeutic decisions in axillary node-negative breast

Elledge RM, McGuire WL. Annu Rev Med. 1993;44:201-10.

DNA ploidy and cell-cycle analysis: tools for assessment of cancer prognosis. - DNA ploidy and cell-cycle analysis: tools for assessment of cancer prognosis.

Aziz DC, Peter JB. J Clin Lab Anal. 1991;5(6):422-38.